Inflammation Markers in Athletes: CRP and Recovery
Table of Contents
Introduction
C-reactive protein (CRP) is the most widely measured inflammatory marker in clinical practice, yet its interpretation in athletic populations is often misunderstood. Understanding inflammation markers in athletes is therefore essential for making accurate clinical decisions. In athletes, an elevated CRP can cause confusion and understandable concern, even though in many cases it reflects a normal physiological response to recent training rather than underlying pathology.
In clinical practice, context matters. If my patient presents with an elevated CRP shortly after a demanding training session or competition, I am often less concerned, as this may reflect a normal response to recent exertion. At the same time, it remains important to consider other potential causes, including infection or non-exercise-related inflammation—particularly if the elevation is disproportionate, persistent, or accompanied by symptoms.
A result that would raise concern in a sedentary patient may be entirely expected in a runner three days after a hard race. Conversely, persistently elevated CRP in an overtrained athlete carries a different clinical significance than the transient spike seen after a single demanding session.
In this article, I examine what CRP actually tells us in the context of sport, how its trajectory differs between acute exercise stress and chronic overload, and what the evidence suggests about using it to guide smarter recovery decisions.
Inflammation Markers in Athletes: What CRP Actually Tells Us
CRP is an acute-phase protein produced by the liver in response to tissue damage, infection, or inflammation anywhere in the body. It rises within 6 hours of an inflammatory stimulus and peaks at around 48 hours, making it a reliable but delayed marker of systemic stress. In cardiovascular medicine, high-sensitivity CRP (hs-CRP) levels below 1 mg/L indicate low cardiovascular risk, levels between 1 and 3 mg/L indicate moderate risk, and levels above 3 mg/L indicate elevated risk [1].
For athletes, these thresholds require careful recontextualisation. Exercise itself is a potent stimulus for CRP elevation—and the magnitude of that rise is closely tied to exercise intensity, duration, and the degree of muscle damage involved [2]. Understanding this response is the starting point for interpreting any post-training or post-competition blood result.
Over the long term, regular exercise is known to reduce low-grade systemic inflammation. In my clinical practice, however, this is rarely visible in routine CRP measurements, as the changes are often too subtle to detect. Occasionally, I may observe this in high-sensitivity CRP values, but I always interpret these findings within the broader clinical context.
In theory, interleukin-6 (IL-6) could be a more sensitive marker for low-grade inflammation. In practice, however, it is not routinely available in standard laboratory testing—at least in Finland—and its clinical interpretation is not well standardized. For this reason, we generally rely on high-sensitivity CRP in clinical practice.
The Acute Inflammatory Response to Exercise
Magnitude and Absolute Values
Strenuous exercise triggers a predictable cascade of inflammatory events. This response is central to understanding how inflammation markers in athletes behave under physical stress. During intense or prolonged effort, contracting skeletal muscles sustain microtrauma, glycogen is depleted, and the body’s stress response systems activate simultaneously. CRP rises as part of the liver’s acute-phase response to signals released from damaged muscle tissue and activated immune cells.
The magnitude of this rise can be striking. A systematic review of exercise and CRP reported data from a study of 90 marathon runners in which CRP increased several-fold within 24 hours after a 42-km race, with values returning to baseline within few days [3].
In absolute terms, CRP values in endurance athletes may rise from baseline levels of approximately 1–3 mg/L to 15–25 mg/L after a marathon, and in some cases can reach 20–50 mg/L following ultra-endurance events such as ultramarathons or long-distance triathlons [4].
In my patients, I often see similar CRP values in the context of infection, and levels around 50 mg/L can resemble those seen in bacterial illness. In these situations, careful clinical judgement is essential. Depending on the overall picture, I may choose to monitor the trend with repeat CRP measurements or proceed with further investigations to rule out underlying infection.
Time Course and Mechanisms
Separately, research tracking 86 marathon runners across multiple post-race timepoints found that CRP remained significantly elevated at 24, 48, 96, 144, and 192 hours after race completion [4]. Together, these findings illustrate both the potential magnitude of the acute post-endurance inflammatory response and its prolonged resolution timeline. Individual variation is substantial, with factors including fitness level, running economy, and pacing strategy all influencing the degree and duration of CRP elevation.
Intensity matters significantly. CRP elevations are greater following high-intensity effort than moderate exercise, and peaks generally occur at around 24 hours post-activity rather than immediately after completion [2]. This delayed peak is clinically important: an athlete who tests their CRP in the first hours after a race may see a misleadingly normal result, only to register a much higher value the following day.
Alongside CRP, interleukin-6 (IL-6) rises steeply during exercise. IL-6 is produced by contracting skeletal muscle—in this context it functions as a myokine rather than a traditional pro-inflammatory cytokine—and it plays a central role in driving hepatic CRP production [5]. Muscle-derived IL-6 during exercise appears to contribute to metabolic and anti-inflammatory adaptations, rather than simply reflecting pathological immune activation [5]. The distinction matters clinically: post-exercise CRP elevation driven by IL-6 as a myokine is a fundamentally different physiological state from the CRP elevation seen in bacterial infection or systemic inflammatory disease.
In practice, interleukin levels are rarely measured in routine clinical work, and their fluctuations are not something we typically rely on in everyday decision-making. Instead, CRP remains the primary inflammatory marker used in clinical practice due to its availability, stability, and ease of interpretation.
Procalcitonin is also gaining ground in clinical practice, particularly in the evaluation of bacterial infections, although it is still used less routinely than CRP in many settings—at least in Finland. Unlike CRP, however, procalcitonin does not typically rise significantly after exercise, which can help distinguish physiological responses to training from bacterial infection.
Chronic Training: The Anti-Inflammatory Adaptation
One of the most important findings in exercise immunology is that while acute bouts of strenuous exercise transiently raise CRP, chronic exercise training reduces baseline CRP levels—often substantially. This paradox—short-term pro-inflammatory, long-term anti-inflammatory—reflects two fundamentally different physiological states.
A meta-meta-analysis published in 2025 synthesising 25 systematic reviews and meta-analyses, encompassing 30,017 participants, found that exercise intervention was associated with a significantly lower mean CRP level (pooled mean effect −0.380, 95% CI −0.487 to −0.273) [6]. A separate meta-analysis of 83 controlled trials involving 3,769 participants confirmed that exercise training decreases CRP regardless of the age or sex of the participant, with a mean effect size of 0.26 (95% CI 0.18 to 0.34, p<0.001) [7]. The effect was stronger when accompanied by reductions in body mass index, but remained statistically significant even in the absence of weight loss (ES=0.19, p<0.001) [7].
Research on elite Finnish cross-country skiers assessed following an 11-month training and competition season found that these athletes had significantly lower resting CRP concentrations than age- and sex-matched controls (p=0.0232) [8]. This reflects the long-term anti-inflammatory conditioning that well-periodised training produces over time.
The mechanisms underlying this chronic adaptation include reduced adipose tissue mass (adipocytes are a significant source of pro-inflammatory cytokines), improved insulin sensitivity, better endothelial function, and downregulation of basal cytokine production in muscle and immune cells [3].
In my view, low-grade inflammation can be considered a marker of overall health, as many chronic conditions—including type 2 diabetes, cardiovascular disease, and depression—have an underlying inflammatory component. I also see that exercise has beneficial effects across all of these conditions, although its impact is clearly multifactorial and not solely mediated through reductions in inflammation.
When Elevated CRP Is a Warning Signal: Overtraining and Chronic Stress
The picture changes when training loads exceed the athlete’s capacity to recover. When exercise stress is not matched by adequate rest, nutrition, and recovery, the body shifts from a state of productive inflammation and repair to one of chronic, low-grade systemic inflammation. This is thought to be one contributing feature of overtraining syndrome (OTS), a multifactorial condition involving dysregulated cytokine production, oxidative stress, and impaired immune function [9]. It is also associated with changes in hormonal regulation, including alterations in cortisol and testosterone levels, as well as shifts in the testosterone-to-cortisol ratio and other endocrine systems.
Unlike the transient CRP spike that follows a single hard session and resolves within days, CRP elevations associated with overtraining reflect a failure of the inflammatory cascade to resolve between training bouts. No single biomarker reliably diagnoses OTS in isolation, and researchers agree that CRP must be interpreted alongside other markers—creatine kinase, cortisol, testosterone, and clinical symptoms—to provide meaningful information about an athlete’s inflammatory status [10].
In my clinical practice, I approach overtraining primarily as a clinical diagnosis based on the overall picture rather than any single laboratory marker. While lab tests can provide some guidance, I do not rely on them to establish the diagnosis.
I do occasionally measure high-sensitivity CRP, and it may offer some limited insight, but as discussed above, I do not use it to diagnose overtraining in isolation. In practice, I include CRP as part of the basic work-up mainly to exclude alternative causes—such as infection or other inflammatory conditions—rather than to support the diagnosis of overtraining itself.
Summary
In athletes, CRP must always be interpreted in context. Acute elevations following strenuous exercise are common and often reflect a normal physiological response to training rather than pathology. At the same time, similar CRP values may also be seen in infection, which is why clinical judgement remains essential.
Over the longer term, regular training is associated with lower levels of low-grade inflammation, although this effect is often subtle and not always clearly visible in routine laboratory measurements. While markers such as IL-6 may provide more immediate insight into inflammatory responses, they are not used in everyday clinical practice, leaving CRP as the most practical tool.
In my clinical work, I rely on CRP not to diagnose overtraining, but to help exclude alternative causes such as infection. Ultimately, no single biomarker can replace a careful clinical assessment. The key to interpreting inflammatory markers in athletes lies in understanding timing, context, and the broader clinical picture.
References
- https://pubmed.ncbi.nlm.nih.gov/15258556/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6962351/
- https://www.jacc.org/doi/10.1016/j.jacc.2004.12.077
- https://pubmed.ncbi.nlm.nih.gov/31045685/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10092579/
- https://link.springer.com/article/10.1007/s11332-025-01445-3
- https://pubmed.ncbi.nlm.nih.gov/27445361/
- https://link.springer.com/article/10.1007/s42978-022-00186-w
- https://pubmed.ncbi.nlm.nih.gov/40264836/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5640004/
